Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 27, 2015 10:30 PM ET

Biotechnology

Company Overview of CardioVascular BioTherapeutics, Inc.

Key Executives for CardioVascular BioTherapeutics, Inc.

NameBoard RelationshipsTitleAge
Daniel C. Montano No RelationshipsCo-Founder and Chief Executive Officer65
Mickael A. Flaa CPA4 RelationshipsPresident, Chief Financial Officer, Principal Accounting Officer, Treasurer and Director61
Grant Gordon 4 RelationshipsCo-Founder and Vice Chairman53
John W. Jacobs Ph.D.No RelationshipsChief Operating Officer, Chief Scientific Officer and Vice President64
Nabil Dib M.D., M.Sc., F.A.C.C.9 RelationshipsPrincipal Investigator for Phase II Heart Trial--
View More Key Executives

CardioVascular BioTherapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Calvin A. Wallen III 4 RelationshipsCardioVascular BioTherapeutics, Inc.--
Grant Gordon 4 RelationshipsCardioVascular BioTherapeutics, Inc.53
Mickael A. Flaa CPA 4 RelationshipsCardioVascular BioTherapeutics, Inc.61
Jon Ross 4 RelationshipsCardioVascular BioTherapeutics, Inc.--
Robert Schleizer 4 RelationshipsCardioVascular BioTherapeutics, Inc.--
View All Board Members

CardioVascular BioTherapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$480.0K
480.0K
377.8K
Bonus
Not meaningful
Total Short Term Compensation$480.0K
480.0K
463.5K
Total Value of Options
30.8M
Compensation as of Fiscal Year
CardioVascular BioTherapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

The Clorox Company Announces Board Changes
May 15, 2015 12:46 PM ET
Ryan Announces Executive Changes
May 13, 2015 4:55 PM ET
Church & Dwight Co. Inc. Announces Executive Changes
May 07, 2015 10:45 AM ET
Monica Nassif Joins Aunt Fannie's Board of Directors
May 05, 2015 1:32 PM ET
SCA Announces Resignation of Rolf Börjesson as Member of the Board of Directors
May 04, 2015 5:57 AM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CardioVascular BioTherapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.